9.4.2014

ArcDia Receives Frost & Sullivan Award for Point-of-Care Product Leadership!

Frost & Sullivan has recognized mariPOC® as the leading product in rapid diagnostics testing of acute respiratory infectious diseases. Read more: Press Release

You can also read the full Frost&Sullivan Award report: Frost & Sullivan report

ArcDia has entered into an exclusive license agreement with Xinhua Healthcare for the commercialisation of ArcDia’s mariPOC® technology in China

mariPOC® ensures lower probability for C. difficile misdiagnosis with precision

New research data shows that influenza antigen testing correlates best with the infectivity period

Press release: New test for detection of C. difficile infection

New QuickStrepA

Study: Diagnosis of respiratory tract infections caused by human bocavirus 1

New mariPOC influenza A virus test with significantly improved sensitivity

New test for Flu A

World’s fastest antibiotic resistance testing

New mariPOC® Gastro test available

Detection and monitoring of human bocavirus 1 infection by a new rapid antigen test

ArcDia contributes solving the global problem of antimicrobial resistance

Press release: Spanish clinical study demonstrates mariPOC’s excellent performance

ArcDia is developing pandemics preparedness

The diagnostics of group A streptococcus from pharyngeal swab samples by bacterial culture is challenged by a novel mariPOC point of care test.

The Flu Season Has Begun – mariPOC® Helps

Nobel Prize awarded to mariPOC® sister technology

The Evolution of Rapid POC Tests for Infectious Disease Diagnostics: An Exclusive SelectScience Interview

ArcDia Receives Frost & Sullivan Award for Point-of-Care Product Leadership!

ArcDia launches world’s first antigen test for human bocavirus – Press Release

New press release

ArcDia Receives Frost & Sullivan Award for Point-of-Care Product Leadership!

ArcDia International Oy Ltd.

Links

Follow us

Do you want to receive mariPOC® newsletter?